Analyzing the options chain and the chart patterns of ALT Altimmune prior to the earnings report this week, I would consider purchasing the 9usd strike price at the money Calls with an expiration date of 2024-6-21, for a premium of approximately $2.22. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
ALT is a stock in the pharmaceutical and weight-loss drug sector. It was recommended by a friend.It can be followed for the long term. Weekly MACD has recently moved into a sell position. It's not yet at the buying point. There is a decrease in weekly and Monthly volüme.
Breakout from falling wedge at very high volume. This is a GREEN ANT stock NASDAQ:ALT
it might be ridiculous to say but if price were to fall back to 9-10 which even if it were too due to its massive runup in price. A retracement in current price action would only provide another opportunity long if one were to present itself. Currently the chart the left is the daily timeframe and the right is the weekly, currently we are in a range of a...
Spotted this yesterday, got into a early trade that paid off
Analyzing the options chain and the chart patterns of ALT Altimmune prior to the earnings report this week, I would consider purchasing the 3.00usd strike price Puts with an expiration date of 2024-1-19, for a premium of approximately $0.99. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward...
Altimmune had a good run, but right now it's sinking faster than the Titanic. It breached both the 100 and 200 MA on H4 and is on its way down to around $5.
Based on its uptrend, rebound from support and a familiar chart pattern confirmed by my technical indicators, I expect at least half a percent in profits IF ALT exceeds Friday's high of $20.94 during Monday's session.
ALT: Altimmune, Inc 2022-01-31 07:00:00 Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity
ALT: Altimmune, Inc 2021-09-28 07:01:00 Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers
NASDAQ:ALT Possible Scenario: LONG Evidence: Price Action, TP1: 15.50$ to fill the gap Call options, Strike 16$, 10/15/2021 Call options, Strike 18$, 10/15/2021 Call options, Strike 19$, 10/15/2021 *This is my idea and could be wrong 100%.
The company's stock is in the consolidation stage strongly The stock is now buy I do not recommend Stop Loss because you will be taken out by the market makers I cannot say more details about my strategy as it is very confidential
Looks like it wants to go towards $22. Tight stop loss at 12.30.
I am bullish on ALT due to confluence. Option Open Interest shows a wall at £12.00 and $16.00 . EMA 9/50/200 consolidating around 13.50-14.50 where the down trend line meets all 3. As well as the up trend line indicating a pressure point. MACD is giving a buy signal. Bollinger Bands and Donchian Channels are both funneled into this pressure point (both suggest a...
Labeled are the price targets for the breakout uptrend. The ascending stop loss would be used when each level has been used as support.